Is BPC-157 legal?

Regulatory status · reviewed June 1, 2026

Research-use-onlyResearch / preclinical

Not approved by the FDA for human use; sold research-use-only and studied in research contexts.

What that status actually means.

BPC-157 is not approved by the FDA for human use. It is sold labelled for laboratory research only, and that label is a regulatory posture adopted by the seller rather than a statement about safety, quality, or what happens after purchase.

Research-use-only material carries no requirement for the controls that apply to medicines. There is no lot release testing for sterility or endotoxins, no identity verification beyond whatever the seller chooses to provide, no manufacturing inspection, and no recall mechanism if a batch is wrong.

Availability is not legality. A compound being straightforward to buy says nothing about the legal position of possessing or administering it, which varies by jurisdiction and is not resolved by the seller's disclaimer.

The regulatory record for BPC-157.

BPC-157 is not approved by the FDA (or other major regulators) for any indication and remains an investigational/research-use-only compound. The FDA placed it in Category 2 of the 503A bulk-substances review in 2023 (citing significant safety questions and restricting compounding); reporting in 2026 indicates it was later removed from that Category 2 list amid a renewed review; removal is not approval and does not establish safety or efficacy.

Compounding, sport, and jurisdiction.

Three separate regimes govern a compound like this one, and they move independently. US compounding eligibility runs through sections 503A and 503B and the FDA lists that sit under them, which are revised over time as the agency evaluates individual substances. A compound can be widely compounded one year and removed from eligibility the next.

Anti-doping status is set separately by WADA and does not track FDA approval at all. The prohibited list covers peptide hormones, growth factors, related substances and mimetics as categories, which means an unapproved research compound can be firmly prohibited in competition while an approved medicine is permitted with the right documentation.

And none of this is global. Approval, scheduling and import rules differ by country, and a compound registered as a medicine in one jurisdiction can be entirely unapproved in another. Several compounds on this site are prescription medicines in one country and research chemicals in the next.

Not legal advice

This page describes publicly documented regulatory status. It is not legal advice and does not tell you whether obtaining or using this compound is lawful in your jurisdiction or your circumstances.

FAQ.

Is BPC-157 FDA-approved?

No. Not approved by the FDA for human use; sold research-use-only and studied in research contexts.

Is it legal to buy BPC-157?

It is commonly sold labelled for laboratory research use, which is a posture the seller adopts. That labelling does not address whether possessing or administering it is lawful where you are, and the answer varies by jurisdiction.

Can a compounding pharmacy prepare BPC-157?

US compounding is governed by sections 503A and 503B, and the substances eligible for it are tracked on specific FDA lists that change over time. A compound being prepared by a pharmacy is not equivalent to FDA approval, and eligibility for compounding is not permanent.

Is BPC-157 banned in sport?

Anti-doping status is set by WADA and is separate from FDA status. Peptide hormones, growth factors, and their releasing factors are broadly covered by the prohibited list, so a compound can be entirely unapproved as a medicine and still prohibited in competition. Athletes should check the current list directly rather than infer status from regulatory position.

Full BPC-157 profile →All compounds by status
Cite this page

PepCue. “Is BPC-157 legal? FDA and regulatory status.” PepCue, reviewed June 1, 2026. https://www.pepcue.app/legal/bpc-157.

Legal status of related compounds
LarazotideB7-33Pentosan PolysulfateTB-500Thymosin β-4
Compounds